Multiple touches on the double bottom on PFEI have already posted this chart but notice the very strong resistance here, with COVID rearing its ugly head again will vaccine revenue grow again?
1PFE trade ideas
PfizerHi my eyes are seeing big reversal potential on Pfizer share dont miss this trade....
Gooooood Luuuuuuck
$PFE - Are we there yet?NYSE:PFE On August 13th, I stated that closing above $37 is critical to indicate the start of a bullish trend. It went up to the $37 area but retreated and is now following a bearish scenario, having reached the $34 downside risk target.
So, what's next?
If it can close above $35 with significant volume, it could signify the beginning of stabilization.
If it breaks below $34, the next stop is $32, which is likely where the ultimate bottom will be formed.
Why? The last time when PFE traded around $33 the stock had an epic run.
Is such a vicious sell-off warranted? Probably not. However, the market can remain irrational for longer than we can endure.
Follow me for charts and trade ideas.
PFE This chart is UGLY. There is absolutely no bullish momentum in play. A small lotto call position with no stop loss is the only play here although I don't foresee that happening. Not touching this one with a 1000 ft long pole.
Multi year double bottom on PFEI have been eying Pfizer for a long entry for my buy and hold account. PFE destroys competition financially and yet remains at a much lower market cap than Lily and a few others. Yes the company was heavily propped up by the covid vaccines but they were wildly cash flow positive without the vaccines as well. This massive double bottom would play out nicely as a risk-to-reward entry on a reliable long-term company.
PFE, Huge Triangle-Formation With Possible Breakout Ahead!Hello Traders Investors And Community, welcome to this analysis where we are looking at the 4-hour timeframe perspective of stock value PFIZER, the recent events, the current formation structure, what needs to be fulfilled that the stock confirms properly and what are possible trading opportunities when the stock has confirmed. As the main stock-market has recovered from the huge corona-breakdowns seen this year there where stock which gained strength out of the crisis and stocks which just stayed in a bearish state, although the health sector surged in demand because of the health crisis and people wanting to live more sustainable lives PFIZER is still somewhat in a sideways movement where it has to confirm and therefore show the ability that it has the strength to move beyond this sideways correction, therefore, I detected some important and interesting signals which can determine the follow-up destiny.
When looking at my chart you can watch this huge possible ascending-triangle-formation where the stock already confirmed several times the upper and lower boundary, furthermore, it noted several times above the 100- and 400-EMA which you can watch marked in blue and orange in the chart, this is a good sign because on the other side there are stocks which trading below these EMA structures. As the stock is approaching the upper boundary another time now we can expect it to confirm as resistance and therefore move on to test the lower boundary of the triangle-formation another time, when the stock manages to stabilize in this boundary where also a coherent support-cluster lies as you can watch it in my chart the potential is given that the stock goes on to confirm the huge ascending--triangle-formation with a final break above it which will cause the bullish rising and an appointment to higher targets.
For now, it is highly important that the stock holds the substantially lower boundary sustainable and does not fall below it where the possibility is not big currently but it should by no means kept by side easily. Compared to other stocks which already moved above and confirmed new highs this stock has definitely some room to go, the breakout when it happens can be traded the best way with a conservative entry after the upper boundary has confirmed, it is also possible to open up an immediate position but this would be the riskier variety, traders should decide according to individual risk preference, and to secure the proper confirmation it is from high importance that corona increases not heavily again and the real economic situation stabilizes further from the heavy breakdowns because when it does not this can cause bearish rumors in all global markets and therefore possible downside ahead which can invalidate the scenario.
In this manner, thank you for watching, support for more market insight, have a great day, and all the best to you!
There are many roads to prosperity, but one must be taken.
Information provided is only educational and should not be used to take action in the markets.
PFE ReversalLooks like NYSE:PFE is beginning get some news with the FDA approval and it has a gap to fill. Looking at the hammer candle as well, there are many signs of a reversal coming. I have the targets that I plan to take as long as it continues to reverse.
Pfizer Fakeout ChartPfizer (PFE) is showing multiple drives of bullish divergence on the 2D after just breaking the trend line and reclaiming. Quite the interesting chart. The more time that goes by without taking it the newest low, the more likely the bounce.
PFE entering bouncy regionThere are some interesting supports here for PFE on the weekly timeframe. Nice enough for a short-term/medium-term bounce.
PFE 1H interestingPFE on the 1 hour is printing bull div and a similar signature of the previous low. It's also in a long term bouncy region on the weekly from previous year support.
PFELonger term, this feels like a massive failed breakout. I don't know where the bottom is, but I don't think it's here.
PFE - Pfizer drop from medain line.Here's not much on the chart.
But what you see is evident.
The pitchforks median line is respected by price many times. And this time it's the same.
But there's a reason why this time price could flush down to the L-MLH. Indexes are weaker and weaker.
The first profit target for me is either the L-MLH, or the A/R (yellow) line. The Action/Reaction line is projected from above's swing range.
So, there we have another one to the short side.
I have more short charts than longs.
However, I always try to keep my overall portfolio balanced.
How?
There are always industries and sectors which perform to the long side, even when markets tank. It's simple but it takes effort.
Pfizer is getting interesting herePfizer has an interesting long-term trend going back to 1969 that is coming up to multiple layers of support. It has recently put in another drive of weekly bullish divergence. Bounce soon?
PFE looking interestingPfizer is looking interesting from multiple perspectives. Long-term support region. Diagonal from prior cycle lows. Multiple drives of bull divs. Between the 0.618 and 0.702 fibs on the log scale. Will it get a bounce?
Pfizer at HUGE support. New Pandemic?On the monthly chart, Pfizer looks to continue it's push upwards towards higher highs as it currently is losing downwards momentum illustrated by the bullish RSI divergences while it gets closer towards the bottom prices channel support as well as the volume profile point of control.
COVID 2.0 incoming?
Pfizer ($PFE) LongPFE finally breaking above the 20 and 50 day moving averages. 200 day is a bit of a reach at 41 with a big resistance level at 37.5 and 39.5. The 9/1 37.5C traded over 21,000x today. Target = 39-40
PFE, 10d+/-9.19%falling cycle -9.19% more than 10 days.
==================================================================================
This data is analyzed by robots. Analyze historical trends based on The Adam Theory of Markets (20 moving averages/60 moving averages/120 moving averages/240 moving averages) and estimate the trend in the next 10 days. The white line is the robot's expected price, and the upper and lower horizontal line stop loss and stop profit prices have no financial basis. The results are for reference only.
PFE setting up for a move. We are starting a pattern of an island bottom. (Patterns are probabilities until proven correct) As of now we are holding a bullish monthly rsi divergence. Also showing bullish divergences on daily weekly and shorter time frames. The Oi for 9/15 is also loaded. The TA is pointing to PFE brewing something in the pipe line. I would suspect some kind of bullish headline for the stock soon. I think I will be looking for a target of $40. I will be scaling in and out during the process. Still early on this one but just wanted to put it out there. This is just DD not trading advice.
$PFE - could be bottomingNYSE:PFE #Pfizer could be forming a bottom as it shows bullish divergences on MACD and RSI. The William's Percentage Range has exited the oversold zone.
Closing above $37 would indicate a bullish trend, while breaking below $34 would suggest a bearish scenario.
Potential targets - $37, $38, $40, and $42
Downside risk - $34.
$PFE yieahhAnother pharma about to explode?
If we vreak the wedge we can expect $40s.
MACD and RSI curling on Weekly
Yieahh
Bullish Alert : PFEHourly Chart.
The price is still moving into a downtrend, but right now there is a new bullish alert with a bullish test of our EMAs. These scenario is working nearby the trendline which may end-up in a breakout.
Waiting for positive price action in the short term.
PFE | Is this the Bottom? | LONGPfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Pfizer, Inc. NYSE - dailyPrice is approaching monthly Demand zone.
There are chances price will go up after hitting daily demand zone nested in monthly supply zone
